scispace - formally typeset
A

Alexander Ermoshkin

Publications -  31
Citations -  3185

Alexander Ermoshkin is an academic researcher. The author has contributed to research in topics: Light intensity & Layer (electronics). The author has an hindex of 16, co-authored 31 publications receiving 2754 citations.

Papers
More filters
Journal ArticleDOI

Continuous liquid interface production of 3D objects

TL;DR: The continuous generation of monolithic polymeric parts up to tens of centimeters in size with feature resolution below 100 micrometers is demonstrated and critical control parameters are delineated and shown that complex solid parts can be drawn out of the resin at rates of hundreds of millimeters per hour.
Patent

Continuous liquid interphase printing

TL;DR: In this paper, the authors proposed a method of forming a 3D object from a solid polymer from an optically transparent body. But the method requires the body to be partially cured.
Patent

Method and apparatus for three-dimensional fabrication

TL;DR: In this paper, the authors present methods and an apparatus for the fabrication of solid three-dimensional objects from liquid polymerizable materials. But they do not describe a method for their fabrication.
Patent

Method and apparatus for three-dimensional fabrication with feed through carrier

TL;DR: In this paper, a method of forming a 3D object is carried out by providing a carrier and a build plate, the build plate comprising a semipermeable member, and the carrier defining a build region there between, and with the build surface in fluid communication by way of the semipermable member with a source of polymerization inhibitor.
Journal ArticleDOI

Single-Step Fabrication of Computationally Designed Microneedles by Continuous Liquid Interface Production.

TL;DR: A novel additive manufacturing technique called Continuous Liquid Interface Production (CLIP) is utilized to rapidly prototype sharp microneedles with tuneable geometries (size, shape, aspect ratio, spacing) that effectively pierced murine skin ex vivo and released the fluorescent drug surrogate rhodamine.